Dr. Piraye Yurttas Beim, a molecular biologist and entrepreneur, is revolutionizing women's health through her groundbreaking work at Celmatix. With an impressive educational background from the University of Texas at Austin, Cornell University, and the University of Cambridge, Dr. Beim is using her expertise to accelerate precision medicine in women's health. Learn about her journey and the impact she's making in this fascinating interview.

Mark Rampolla, Managing Partner at Ground Force Capital, shares his journey from Peace Corps volunteer to creating a billion-dollar brand. Discover how he navigated the beverage industry, sold to Coca-Cola, and then bought back his company to rebuild it even bigger. Rampolla also discusses his transition into venture capital and the exciting companies in his portfolio.

Deciduous CEO Robin Mansukhani discusses how their company is working on harnessing the immune system to treat diseases of aging. Robin explains the concept of senescent cells and how their accumulation can lead to various age-related diseases such as pulmonary fibrosis, type 2 diabetes, and even dementias. He also shares insights on the potential of longevity therapeutics to revolutionize medicine by targeting multiple indications simultaneously.

Join Dr. Faizzan Ahmad, CEO of Cure8bio, as he explores the frontier of regenerative medicine. From his journey at Oxford to pioneering a hub-and-spoke biotech model, Dr. Ahmad discusses the latest advancements in stem cell therapies, gene editing, and their potential to cure previously untreatable diseases. Learn how these innovations are reshaping the future of healthcare and longevity.

Discover how Yaky Yanay, CEO of Pluri, is revolutionizing regenerative medicine using placenta-derived cells. From combating radiation exposure to potentially extending human lifespan, Yanay shares insights on the future of healthcare and the untapped potential of cellular therapies.

Join Jess Larsen and co-host Greg Bailey as they welcome biohacking legend Bryan Johnson to explore the frontiers of health and longevity. In this episode, uncover Bryan's journey through personal experimentation, advancing the science of biohacking to unlock the secrets of extending life and enhancing wellness. Delve into Bryan's groundbreaking efforts, from pioneering technologies to experimental treatments aimed at reversing aging. Discover the challenges and triumphs of his quest, the profound discoveries made, and the implications these have for the future of human health. Tune in for a compelling look at how cutting-edge research and personal dedication are reshaping our understanding of what it means to live a longer, healthier life.

Lucio Iannone, VP of Venture Investments at Leaps by Bayer, shares insights on the future of biotech investment, focusing on cell therapy and inflammation treatments. Discover how Iannone's unique journey from boxing to biotech has shaped his approach to identifying and nurturing groundbreaking medical technologies.

Gain crucial insights into the world of longevity investing—learn the keys to identifying promising biotech companies and the strategies for reducing investment risks in this burgeoning sector.

Discover how Aaron Alexander helped NFL star Aaron Rodgers achieve the fastest Achilles tendon rupture recovery ever using techniques like blood flow restriction, promoting circulation, and early movement. Learn these game-changing tips to expedite your own injury healing process.

Get an inside look at Hamptons Tech Week, the exclusive micro-conference where thought leaders gather to discuss the future of sports, media, and technology. Discover what makes this curated event so special and hear from attendees about the valuable connections and insights they gained. Learn how you can get involved in future editions.

Discover the immense potential of the longevity biotech field with insights from biotech investor Karl Pfleger. Learn about the explosive growth of longevity companies, the trillion-dollar market opportunities, and the key scientific areas driving the field forward. If you're an investor looking for the next big thing, you won't want to miss this episode.

The field of aging research is undergoing a revolution, and the Buck Institute is at the forefront of this transformative movement. In this captivating interview, Dr. Eric Verdin shares insights into the groundbreaking discoveries that are redefining our understanding of the aging process. From senescence and epigenetics to NAD metabolism and ketones, learn about the cutting-edge science that is paving the way for a future where age-related diseases are a thing of the past. Join us as we explore the exciting possibilities of the longevity revolution.

In this insightful podcast episode, Dr. Jeff Karp shares powerful strategies to tap into your brain's neuroplasticity and rewire it for success. Discover how small changes in your daily life can lead to significant improvements in creativity, problem-solving, and overall well-being. Learn to intercept routine patterns and algorithms that limit your potential, and embrace a mindset of continuous learning and growth. Dr. Karp's new book, called LIT: Life Ignition Tools and his research at Harvard Medical School and MIT provides a scientific foundation for these life-changing techniques.

Discover how Bayer's Leaps Venture Capital arm is transforming the biotech landscape by investing in cutting-edge therapies and technologies. Lucio Iannone, a leading investor at Leaps, shares insights into their unique approach and the future of healthcare.

What can we learn from an investor who has deployed over $100 million into longevity-focused biotech startups? Alex Colville shares his biggest takeaways, from the importance of founder-market fit to the need to challenge assumptions in a nascent field.

Raising money for longevity research can be a daunting task, especially for founders without a traditional biotech background. Akshay Sangahvi shares his experiences and insights on overcoming these challenges and securing funding for Yuvan Research.

Join Jess Larsen and guest Greg Bailey in an insightful episode on "Longevity for Investors." Learn about transforming health and investing from a medical doctor turned entrepreneur with a track record in building billion-dollar companies. Discover the market potential of longevity drugs, the importance of great management, and the criteria for evaluating successful ventures. Greg shares personal success stories and offers valuable advice for new investors in the longevity sector.

The Buck Institute, a pioneer in aging research, is uncovering how ketones impact healthspan. Dr. Brianna Stubbs, a world-champion athlete turned researcher, shares insights on how these molecules are more than just an energy source. They act as potent signaling molecules, influencing key aging pathways. Learn about the institute's groundbreaking work and how ketone drinks might help us live better, longer.